Revvity, Inc.

RVTY Healthcare · Diagnostics & Research
Delayed 15 min
Last close
$111.21
Jun 29, 2026
52-week range
$81.22 — $118.30
-6% from high
Market cap
12.4B
Diluted basis
Dividend yield
25.0%
P/E
53.5
Trailing
Filing.fyi verdict · Jun 29, 2026

Fairly valued.

Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.

Neutral Beneish: -2.46Altman Z″: 2.46Piotroski: 6/9Fog: 15.0
RED DEEP 74 / 100
Composite Health
Forensic readings · derived from the latest filing

The four readings.

Each score answers a different question. The composite at the top is the average; the disagreement below is the story.
Beneish M Earnings manipulation
-2.46
Clean
−3.0 threshold −1.78 +1.0
Altman Z″ Bankruptcy proximity
2.46
Grey zone
0 threshold 1.10 / 2.60 4.0
Piotroski F Fundamental health (0–9)
6
Mixed
0 threshold 6+ 9
Fog Index MD&A readability
14.98
Dense
8 threshold ≥ 18 = murky 24
AI synthesis · grounded in this ticker's SEC filings · drag to highlight, releases the composer

What the filing actually says.

AI · wry-editorial preset

Revvity’s 2025 10-K begins its Management’s Discussion and Analysis (MD&A) with a prominent disclaimer regarding forward-looking statements — statements about future events or financial performance, often with caveats. The company explicitly notes that “any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements.” This framing sets the stage for the entire discussion, immediately directing the reader to consider the inherent uncertainties in financial projections. The MD&A further advises that “actual results may differ materially” from these forward-looking statements, pointing to “Risk Factors” in Item 1A for details.

The forensic scores offer a mixed but generally stable picture. Beneish’s 1999 eight-ratio earnings-manipulation detector, the M-Score, registers at -2.4615, which is below the -1.78 threshold, suggesting lower risk of earnings manipulation. Altman’s Z″ — a 1968 bankruptcy-distress index — comes in at 2.46, placing Revvity in the 1.10–2.60 “grey zone,” indicating neither clear financial distress nor robust safety. Piotroski’s F-Score, a 9-point fundamental strength scan, stands at 6.0, a respectable score that does not flag significant operational weakness.

The MD&A’s opening serves as a crucial pedagogical moment, highlighting the distinction between historical fact and future expectation. The company’s emphasis that actual results may differ materially from its plans, intentions, or expectations is a standard but vital disclosure. It underscores the importance of reviewing the “Risk Factors” in Item 1A, which the MD&A explicitly references for the specific factors that could cause such divergences. While the excerpt for Item 1A is largely structural, its presence as a dedicated section for these material factors is consistent with the MD&A’s cautionary tone.

This filing, through its forensic scores and MD&A framing, provides a snapshot of Revvity’s financial health and disclosure practices. The Fog Index — readability score; 12 = newspaper, 18+ = obfuscatory — of 14.98 suggests the document is reasonably accessible, not intentionally obscured. However, this reading cannot predict market movements or establish a definitive valuation. It merely interprets the company’s self-reported financial posture and the clarity with which it communicates its outlook.

SEC filings · last 12 months

Filing timeline

View all on EDGAR →
  • May 5, 2026
    8-K
    Material event (2026-05-05)### Item 2.02 of Form 8-K (including Exhibit 99 .1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange0
    Read →
  • May 1, 2026
    8-K
    Material event (2026-04-28)### Item 5.03 Amendments to Articles of Organization or Bylaws; Change in Fiscal Year At the annual meeting of shareholders of Revvity, Inc . (the “Company”) he0
    Read →
  • Mar 16, 2026
    DEF 14A
    Proxy statement (2026-04-28)0
    Read →
  • Feb 24, 2026
    10-K
    Annual report (2025-12-28)Period: 2025-12-280
    Read →
  • Feb 2, 2026
    8-K
    Material event (2026-02-02)### Item 2.02 shall be deemed to be furnished, and not filed . SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has0
    Read →
  • Nov 4, 2025
    10-Q
    Quarterly report (2025-09-28)Period: 2025-09-280
    Read →
Member feature · Custom Q&A
Ask anything about RVTY's filings.
Plain-English answer, cited from the company's own 10-K and recent 10-Qs. No buy/sell advice.
Ask a question →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →
Quality of Earnings

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →